What is Miracles?
Miracles operates as a specialized nonprofit organization at the intersection of medical technology and humanitarian healthcare. Its core competency lies in the sophisticated management of eye banking, providing essential tissue preparations and innovative autologous serum eye drops that are vital for modern corneal transplant procedures. By bridging the gap between donor availability and surgical necessity, the company serves as a foundational pillar for transplant partners and researchers worldwide.
The organization's market position is defined by its commitment to the advancement of sight-restoring treatments. Through strategic collaborations and a focus on technical excellence, Miracles facilitates complex surgical processes, effectively acting as a supply chain leader in the ocular health industry. Its operational model is designed to maximize the utility of donated tissue, ensuring that every resource is optimized for patient outcomes.
How much funding has Miracles raised?
Miracles has raised a total of $2.1M across 2 funding rounds:
Debt
$1M
Debt
$1.1M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.1M led by PPP
Key Investors in Miracles
PPP
Public-Private Partnership
What's next for Miracles?
Looking ahead, the strategic deployment of this recent funding will likely focus on the modernization of tissue processing facilities and the acceleration of research initiatives aimed at improving surgical success rates. As the organization navigates the complexities of the healthcare sector, the focus will remain on scaling its distribution networks and enhancing the efficacy of its proprietary eye drop formulations. By maintaining a robust financial foundation, Miracles is well-positioned to address the increasing global demand for corneal transplants and related ocular therapies, ensuring long-term sustainability and continued innovation in the field of vision restoration.
See full Miracles company page